Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
Clinical trial NCT04994808 · TERMINATED
Trial details
- NCT number
- NCT04994808
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-11
- Primary completion
- 2026-01-22
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.